Risk of iodinated contrast material-induced nephropathy with intravenous administration

Richard W Katzberg, Brendan J. Barrett

Research output: Contribution to journalReview article

115 Scopus citations


The apparently lower risk of contrast material (CM)-induced nephropathy associated with intravenous CM administration in clinical settings such as contrast-enhanced multidetector CT makes it defensible to consider using CM even in patients with greater levels of background risk factors (eg, greater degrees of preexisting chronic renal insufficiency) than one would be comfortable with in the intraarterial setting, as long as there is a clear indication for the diagnostic examination.

Original languageEnglish (US)
Pages (from-to)622-628
Number of pages7
Issue number3
StatePublished - Jun 2007


ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this